108392-00-3

Basic information

• Product Name: 1-O-[BETA-D-GALACTOPYRANOSYL]-N-HEXADECANOYL-DL-DIHYDRO-SPHINGOSINE
• Synonyms: 1-O-[BETA-D-GALACTOPYRANOSYL]-N-HEXADECANOYL-DL-DIHYDRO-SPHINGOSINE;N-PALMITOYL-DL-DIHYDRO-GALACTOCEREBROSIDE;1-o-(β-d-galactopyranosyl)-n-hexadecanoyl-dl-dihydrosphingosine
• CAS NO: 108392-00-3
• Molecular Formula: C40H79NO8
• Molecular Weight: 702.06
• Mol File: 108392-00-3.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 835.8°C at 760 mmHg
• Flash Point: 459.3°C
• Appearance: /
• Density: 1.05g/cm³
• Vapor Pressure: 1.94E-32mmHg at 25°C
• Refractive Index: 1.51
• Storage Temp.: −20°C
• CAS DataBase Reference: 1-O-[BETA-D-GALACTOPYRANOSYL]-N-HEXADECANOYL-DL-DIHYDRO-SPHINGOSINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-O-[BETA-D-GALACTOPYRANOSYL]-N-HEXADECANOYL-DL-DIHYDRO-SPHINGOSINE(108392-00-3)
• EPA Substance Registry System: 1-O-[BETA-D-GALACTOPYRANOSYL]-N-HEXADECANOYL-DL-DIHYDRO-SPHINGOSINE(108392-00-3)

Safety Data

• Hazardous Substances Data: 108392-00-3(Hazardous Substances Data)

Usage

Structure

Comprised of a ceramide moiety and a galactose sugar.

Explanation

Lactosylceramide consists of a sphingoid base (sphingosine) amide-linked to a fatty acid (hexadecanoic acid) and a galactose sugar attached to the ceramide.

Explanation

Lactosylceramide acts as a mediator in various cellular processes by interacting with other membrane components and participating in signal transduction pathways. It also helps in cell-to-cell interactions and maintaining cellular adhesion.

Explanation

Lactosylceramide has been found to play a role in the regulation of immune responses, promotion or suppression of cancer cell growth, and glucose homeostasis in diabetes.

Explanation

Studies have suggested that lactosylceramide may be involved in the pathogenesis of neurodegenerative diseases, such as Alzheimer's and Parkinson's, by affecting neuronal function and survival.

Explanation

Lactosylceramide's role in various biological processes makes it a potential target for the development of new therapies for diseases like cancer and neurodegenerative disorders.

Explanation

The levels of lactosylceramide have been found to be altered in certain disease states, making it a potential biomarker for diagnosis, prognosis, or monitoring treatment response.

Occurrence

Found in cell membranes.

Biological function

Involved in cell signaling and cell adhesion.

Implication in biological processes

Immune function, cancer progression, and diabetes.

Association with neurodegenerative diseases

Development of neurodegenerative diseases.

Therapeutic potential

Target for therapeutic intervention.

Biomarker potential

Use as a biomarker for certain diseases.

InChI:InChI=1/C40H79NO8/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-34(43)33(32-48-40-39(47)38(46)37(45)35(31-42)49-40)41-36(44)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h33-35,37-40,42-43,45-47H,3-32H2,1-2H3,(H,41,44)